Oxaliplatin Solution For Injection 5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Oxaliplatin: Solution for injection (5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

OXALIPLATIN (ox AL i PLA tin) is a chemotherapy drug. It targets fast dividing cells, like cancer cells, and causes these cells to die. This medicine is used to treat cancers of the colon and rectum, and many other cancers.

Similar Brand Name Drugs : Eloxatin: Solution for injection (5mg)
In-Depth Information
Select a Medication

Oxaliplatin 100mg/20ml Solution for Injection

NDC: 667580053
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Colorectal Cancer

Sometimes used for but not FDA approved for the following conditions:
Breast Cancer, Testicular Cancer, Non-Hodgkin's Lymphoma (NHL), Biliary Tract Cancer, Mesothelioma, Gastric Cancer, Pancreatic Cancer, Ovarian Cancer, Head And Neck Cancer

Storage Information
Protect from light
Store in carton
Do not freeze
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Oxaliplatin 100mg/20ml Solution for Injection

Reported Side Effects for Oxaliplatin 100mg/20ml Solution for Injection

Chest Pain Incidence:
<1.0%*
Severity: SEVERE
Onset: EARLY
Back Pain Incidence:
<3.0%*
Severity: SEVERE
Onset: DELAYED
Moschcowitz Syndrome Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Pulmonary Fibrosis Incidence:
<1.0%*
Severity: SEVERE
Onset: DELAYED
Muscle Pain Incidence:
<2.0%*
Severity: SEVERE
Onset: EARLY
Brain Deterioration Incidence:
<0.1%*
Severity: SEVERE
Onset: DELAYED
Low Blood Pressure Incidence:
<3.0%*
Severity: SEVERE
Onset: RAPID
Intestinal Bleeding Incidence:
0.2%*
Severity: SEVERE
Onset: DELAYED
Hand And Foot Syndrome Incidence:
1.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Secretion Of Tears Incidence:
1.0-9.0%*
Severity: MILD
Onset: EARLY
Anemia Incidence:
1.0-3.0%*
Severity: SEVERE
Onset: DELAYED
Dysesthesia Incidence:
1.0-2.0%*
Severity: SEVERE
Onset: DELAYED
Heartburn Incidence:
1.0-5.0%*
Severity: MILD
Onset: DELAYED
Gum Inflammation Incidence:
2.0-4.9%*
Severity: MILD
Onset: DELAYED
Fainting Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Bruises Incidence:
2.0-4.9%*
Severity: MILD
Onset: DELAYED
Hemorrhoids Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Bone Pain Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Incoordination Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: DELAYED
Melena Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Cough Incidence:
2.0-35.0%*
Severity: MILD
Onset: DELAYED
Painful Urination Incidence:
2.0-6.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
2.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Diaphoresis Incidence:
2.0-4.9%*
Severity: MILD
Onset: EARLY
Hypoxia Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: EARLY
Depression Incidence:
2.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Hiccups Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Coughing Up Blood Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Weight Loss Incidence:
2.0-11.0%*
Severity: MILD
Onset: DELAYED
Sore Throat Incidence:
2.0-9.0%*
Severity: MILD
Onset: DELAYED
Lung Inflammation Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Rectal Infection Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Itching Incidence:
2.0-4.9%*
Severity: MILD
Onset: RAPID
Weakness Incidence:
2.0-5.0%*
Severity: MILD
Onset: EARLY
Low Platelet Count Incidence:
2.0-5.0%*
Severity: SEVERE
Onset: DELAYED
High Blood Pressure Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: EARLY
Uncontrolled Urination Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: EARLY
Hives Incidence:
2.0-4.9%*
Severity: MILD
Onset: RAPID
Balance Problems Incidence:
2.0-4.9%*
Severity: MILD
Onset: EARLY
Dry Skin Incidence:
2.0-4.9%*
Severity: MILD
Onset: DELAYED
Dry Mouth Incidence:
2.0-4.9%*
Severity: MILD
Onset: EARLY
Nervousness Incidence:
2.0-6.0%*
Severity: MILD
Onset: DELAYED
Intestinal Blockage Incidence:
2.0-4.9%*
Severity: SEVERE
Onset: DELAYED
Tenesmus Incidence:
2.0-4.9%*
Severity: MILD
Onset: DELAYED
Extra Abdominal Fluid Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: DELAYED
Hot Flashes Incidence:
2.0-4.9%*
Severity: MODERATE
Onset: EARLY
Infection Incidence:
2.0-25.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
2.0-5.0%*
Severity: MODERATE
Onset: RAPID
Hair Loss Incidence:
3.0-38.0%*
Severity: MILD
Onset: DELAYED
Flushing Incidence:
3.0-10.0%*
Severity: MILD
Onset: RAPID
Low Potassium Levels Incidence:
3.0-11.0%*
Severity: MODERATE
Onset: DELAYED
Gas Incidence:
3.0-9.0%*
Severity: MILD
Onset: EARLY
Skin Rash Incidence:
5.0-11.0%*
Severity: MILD
Onset: EARLY
Increased Urination Incidence:
5.0%*
Severity: MILD
Onset: EARLY
Joint Pain Incidence:
5.0-10.0%*
Severity: MILD
Onset: DELAYED
Dehydration Incidence:
5.0-9.0%*
Severity: MODERATE
Onset: DELAYED
Fluid Retention Incidence:
5.0-10.0%*
Severity: MODERATE
Onset: DELAYED
Metallic Taste Incidence:
5.0-14.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
5.0-20.0%*
Severity: MODERATE
Onset: EARLY
Rhinitis Incidence:
6.0-15.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
6.0-18.0%*
Severity: SEVERE
Onset: DELAYED
Blood In The Urine Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Blood Clot Incidence:
6.0-9.0%*
Severity: SEVERE
Onset: DELAYED
High Bilirubin Level Incidence:
6.0-20.0%*
Severity: MODERATE
Onset: DELAYED
Low Lymphocytes Incidence:
6.0%*
Severity: MODERATE
Onset: DELAYED
Injection Site Reaction Incidence:
6.0-11.0%*
Severity: MILD
Onset: RAPID
Elevated Hepatic Enzymes Incidence:
6.0-57.0%*
Severity: MODERATE
Onset: DELAYED
Low Calcium Levels Incidence:
7.0%*
Severity: MODERATE
Onset: DELAYED
Lightheadedness Incidence:
7.0-13.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
7.0-14.0%*
Severity: MILD
Onset: EARLY
Headache Incidence:
7.0-13.0%*
Severity: MILD
Onset: EARLY
Nerve Pain Incidence:
7.0-19.0%*
Severity: SEVERE
Onset: DELAYED
Low Blood Sodium Levels Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Low Albumin In Blood Incidence:
8.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
9.0-13.0%*
Severity: MILD
Onset: EARLY
Nose Bleed Incidence:
9.0-16.0%*
Severity: MILD
Onset: DELAYED
Weight Gain Incidence:
10.0%*
Severity: MILD
Onset: DELAYED
Swelling Incidence:
10.0-15.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
12.0-18.0%*
Severity: SEVERE
Onset: DELAYED
Decreased Appetite Incidence:
13.0-35.0%*
Severity: MILD
Onset: DELAYED
Increased Blood Sugar Incidence:
14.0%*
Severity: MODERATE
Onset: DELAYED
Mouth Ulcers Incidence:
14.0-42.0%*
Severity: MODERATE
Onset: DELAYED
Fever Incidence:
16.0-29.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
18.0-33.0%*
Severity: MILD
Onset: EARLY
Low White Blood Cell Counts Incidence:
19.0-20.0%*
Severity: SEVERE
Onset: DELAYED
Constipation Incidence:
22.0-32.0%*
Severity: MODERATE
Onset: DELAYED
Vomiting Incidence:
37.0-47.0%*
Severity: MILD
Onset: EARLY
Tired Incidence:
44.0-70.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
46.0-67.0%*
Severity: MILD
Onset: EARLY
Upset Stomach Incidence:
64.0-74.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Oxaliplatin

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5